Modern psychiatric treatment: A tribute to Thomas Detre, MD (1924-2011)

Psychotherapy and Psychosomatics

Volumn 82, Issue 1, 2013, Pages 1-7

  Fava, Giovanni A ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HISTORY; HUMAN; METHODOLOGY; PSYCHIATRY;

HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PSYCHIATRY;

EID: 84868603112     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000343002     Document Type: Review

References (48)

1. Detre TP, Jarecki HG: Modern Psychiatric Treatment. Philadelphia, Lippincott, 1971
2. Fava GA, Rafanelli C, Tomba E: The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry 2012, 73: 177-184
3. Fava GA: Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 1999, 29: 47-61
4. Fava GA, Mangelli L: Subclinical symptoms in panic disorder. Psychother Psychosom 1999, 68: 281-289
5. Fava GA, Kellner R: Prodromal symptoms in affective disorders. Am J Psychiatry 1991; 148: 823-830
6. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA: Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151: 1295-1299
7. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R: Four year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996, 153: 945-947
8. Fava GA, Tomba E: New modalities of assessment and treatment planning in depression. CNS Drugs 2010, 24: 453-465
9. Fava GA, Kellner R: Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand 1993, 87: 225-230
10. Westen D: Prototype diagnosis of psychiatric syndromes. World Psychiatry 2012, 11: 16-21
11. Tyrer P, Seivewright N, Ferguson B, Tyrer J: The general neurotic syndrome. Acta Psychiatr Scand 1992, 85: 201-206
12. Engel GL: Physician-scientists and scientific physicians. Resolving the humanism-science dichotomy. Am J Med 1987, 82: 107-111
13. Fava GA: Clinical judgment in psychiatry: requiem or reveille? Nord J Psychiatry 2012, E-pub ahead of print
14. Whitley R, Rousseau C, carpenter-Song E, Kirmayer LJ: Evidence-based medicine: opportunities and challenges in a diverse society. Can J Psychiatry 2011, 56: 514-522
15. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS: Evidence based medicine: what it is and what it isn't. BMJ 1996, 312: 71-72
16. Feinstein AR, Horwitz RI: Problems in the 'evidence' of 'evidence-based medicine'. Am J Med 1997, 103: 529-535
17. Kellner R: Personality disorders, in Greist JH, Jefferson JW, Spitzer RL (eds): Treatment of Mental Disorders. New York, Oxford University Press, 1982, pp 429-449
18. Woodcock J: Assessing the clinical utility of diagnostics used in drug therapy. Clin Pharmacol Ther 2010, 88: 765-773
19. De Leon J: Evidence-based medicine versus personalized medicine. Are they enemies? J Clin Psychopharmacol 2012, 32: 143-164
20. Tomba E: Nowhere patients. Psychother Psychosom 2012, 81: 69-72
21. Horwitz RI, Singer BH, Makuch RW, Viscoli CM: Can treatment that is helpful on average be harmful to some patients? J Clin Epidemiol 1996, 49: 395-400
22. Fava GA, Offidani E: The mechanisms of tolerance in antidepressant action. Progr Neuropsychopharmacol Biol Psychiatry 2011, 35: 1593-1602
23. Cella M, Chalder T, White PD: Does the heterogeneity of chronic fatigue syndrome moderate the response to cognitive behavior therapy? An exploratory study. Psychother Psychosom 2011, 80: 353-358
24. Feinstein AR: An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J Biol Med 1973, 46: 212-232
25. Emmelkamp PMG, Bouman TK, Scholing A: Anxiety Disorders. Chichester, Wiley, 1993
26. Tomba E, Fava GA: Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am 2012, 35: 87-98
27. Fava GA, Sonino N, Wise TN (eds): The Psychosomatic Assessment. Karger, Basel, 2012
28. Cosci F, Fava GA: New clinical strategies of assessment of comorbidity associated with substance use disorders. Clin Psychol Rev 2011, 31: 418-427
29. Feinstein AR: The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis 1970, 23: 455-468
30. deGroot V, Beckerman H, Lankhorst GJ, Bouter LM: How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003, 56: 221-225
31. Taylor GJ: Affects, trauma, and mechanisms of symptom formation. A tribute to John C. Nemiah, MD (1918-2009). Psychother Psychosom 2010, 79: 339-349
32. Lichtenberg P, Belmarker RH: Subtyping major depressive disorder. Psychother Psychosom 2010, 79: 131-135
33. Bech P: The struggle for subtypes in primary and secondary depression and their modespecific treatment or healing. Psychother Psychosom 2010, 79: 331-338
34. Guidi J, Fava GA, Picardi A, Porcelli P, Bellomo, Grandi S, Grassi L, Pasquini P, Quartesan R, Rafanelli C, Rigatelli M, Sonino N: Subtyping depression in the medically ill by cluster analysis. J Affect Disord 2011, 132: 383-388
35. Fava GA, Sonino N: Depression associated with medical illness. CNS Drugs 1996, 5: 175-189
36. Tomba E, Bech P: Clinimetrics and clinical psychometrics: macro-and micro-analysis. Psychother Psychosom 2012, 81: 333-343
37. Bielski RJ, Friedel RO: Prediction of tricyclic antidepressant response. A critical review. Arch Gen Psychiatry 1976, 33: 1479-1489
38. Joosten EAG, De Fuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ: Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008, 77: 219-226
39. Joosten EAG, de Jong CAJ, de Weert-van Oene GH, Sensky T, van der Staak CPF: Shared decision making reduces drug use and psychiatry severity in substance-dependent patients. Psychother Psychosom 2009; 78: 245-253
40. Rickels K: Psychopharmacologic agents. J Nerv Ment Dis 1963, 136: 540-549
41. Fava GA: The intellectual crisis of psychiatric research. Psychother Psychosom 2006, 75: 202-208
42. Gliedman CH, Nash EH, Huber SD, Stone AR, Frank JD: Reduction of symptoms by pharmacologically inert substances and by short-term psychotherapy. AMA Arch Neurol Psychiatry 1958, 79: 345-351
43. Downing RW, Rickels K: Nonspecific factors and their interaction with psychological treatment in pharmacotherapy, in Lipton MA, Di Mascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven, 1978, pp 1419-1427
44. Uhlenhuth EN, Rickels K, Fisher S, Park LC, Lipman RS, Mock J: Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia 1966, 9: 392-418
45. Fava GA, Park SK, Dubovsky SL: The mental health clinic: a new model. World Psychiatry 2008, 7: 177-181
46. Wright Mills C: The Sociological Imagination. Fortieth Anniversary Edition. Oxford, Oxford University Press, 2000
47. Smith HL: Psychiatry in medicine: intra-or inter-professional relationships? Am J Sociol 1957, 63: 285-289
48. Engel GL: From biomedical to biopsychosocial. Psychother Psychosom 1997, 66: 57-62.